PilLow RX

PilLow addresses the underlying cause of chronic insomnia by guiding patients to modify their thought processes and behavior for better sleep. PilLow's underlying mechanism, Cognitive Behavioral Therapy for Insomnia (CBT-i), is the guideline-recommended first-line therapy for insomnia.

Insomnia in Korea

Source: Health Insurance Review & Assessment Service

Source: OECD


increase in the number of patients over 10 years


increase in healthcare cost over 4 years


of Koreans suffer from chronic insomnia

Source: Health Insurance Review & Assessment Service Korean Sleep Research Society

The unmet needs of insomnia

Sleep medications are only recommended for short term use and may have unwanted side-effects

Sleeping pills help induce and maintain sleep, but do not solve the underyling cause.

Limited access to first-line treatment: Cognitive Behavioral Therapy (CBT)

Limited number of CBTi accredited providers

What is CBT-I?

CBT-I (I for Insomnia) coaches patients to identify feelings, thoughts and behaviors that are contributing to the symptoms of insomnia and helps reframe any misconceptions for better sleep.

Why CBT-I?

The American College of Physicians recommends CBT-I as the first-line treatment for all adults with chronic insomnia. Because CBT-I is noninvasive, it is likely to have fewer harms, whereas sleeping pills can be associated with serious adverse events. It is also known to have better long term efficacy over pharmacotherapy. With more than 20 years of research, CBT-I has become the gold standard of insomnia care.

Changes in Sleep Efficiency, %

Changes in Sleep Latency, %

Source: Jacobs, Gregg D., et al. (2004)